The Impact of COVID-19 on Clinical Trials
- PMID: 32541234
- PMCID: PMC7467053
- DOI: 10.1097/SLA.0000000000004113
The Impact of COVID-19 on Clinical Trials
Conflict of interest statement
The authors report no conflicts of interest.
References
-
- The Center for Systems Science and Engineering (CSSE) at Johns Hopkins University. Coronavirus COVID-19 Global Cases. Available at: https://gisanddata.maps.arcgis.com/apps/opsdashboard/index.html#/bda7594.... Accessed April 26, 2020.
-
- Livingston E, Desai A, Berkwits M. Sourcing personal protective equipment during the COVID-19 pandemic. JAMA 2020; 323:1912–1914. doi:10.1001/jama.2020.5317. - PubMed
-
- National Library of Medicine. ClinicalTrials.gov. Available at: https://clinicaltrials.gov. Accessed April 26, 2020.
-
- Food and Drug Administration. FDA Guidance on Conduct of Clinical Trials of Medical Products During COVID-19 Public Health Emergency. March 2020. Updated April 16, 2020. Available at: https://www.fda.gov/media/136238/download. Accessed May 2, 2020.
-
- Medicines and Healthcare products Regulatory Agency Inspectorate. Advice for Management of Clinical Trials in Relation to Coronavirus. March 12, 2020. Available at: https://mhrainspectorate.blog.gov.uk/2020/03/12/advice-for-management-of.... Accessed May 2, 2020.
MeSH terms
LinkOut - more resources
Full Text Sources
Medical